Digital Health Research

Digital Health’s Transformative Role in Biopharma Research

Name: Digital Health in Oncology (Premium)
Brand: Galen Growth
Availability: InStock

Report access and advisory support are available through Galen Growth.

In this report, Galen Growth presents our most recent findings on how Digital Health can leverage technology to revolutionize biopharma research. This focused report provides insights on how emerging technologies, including artificial intelligence (AI) and generative AI, are transforming the industry. Our analysis focuses on private ventures in the space and examines partnering activity. ...

View

Digital Health’s Transformative Role in Biopharma Research (mini-report)

Description

The healthcare sector is undergoing a substantial transformation driven by advancements in artificial intelligence (AI) and generative AI (GenAI). These groundbreaking technologies are reshaping drug discovery, disease diagnosis, treatment, and prevention approaches. To keep pace with these innovations in precision medicine and drug discovery, pharmaceutical firms are increasingly partnering with research solution providers. In this report, Galen Growth presents our latest insights into how Digital Health can utilize technology to revolutionize biopharma research, highlighting its transformative role.

Key Insights

The landscape of partnerships between biopharma and Digital Health underwent a significant transformation in 2020, marking a pivotal shift in focus. Notably, 36% of Biopharma partnerships announced in 2022 were specifically tailored towards providing solutions for advancing Biopharma research, signifying a strategic redirection within the industry.
Over the past half-decade, Oncology has risen as the foremost therapeutic area for ventures aligning with biopharma companies. This substantial trend underscores the growing synergy between these sectors and the critical emphasis placed on advancing cancer research and treatment through collaborative efforts.
Research Solutions, encompassing domains such as Drug Discovery, Omics-related Research, and Bioinformatics, stands out prominently. This cluster reigns as the preferred domain for collaborations between Digital Health ventures employing GenAI and Biopharma companies. The convergence of innovative technologies and specialized research solutions highlights the critical role of GenAI in reshaping biopharma research landscapes, fostering advancements in precision medicine, and propelling novel therapeutic developments.

This Global Digital Health Innovation Thematic Report on Generative AI in Digital Health includes data on the following companies:

Atomwise, Athelas, Insilico Medicine, Atropos, data iku, Huma, Medii, PathAI, Biorelate, Nye Health, PicnicHealth, Anumana, Roche, AstraZeneca, Novartis, Pfizer, Bayer

HealthTech Alpha, a Galen Growth proprietary solution, and the global leading Digital Health private market data, intel and insights platform powers this report!

Missed our last report?

Get access to HealthTech Alpha and read our Generative AI in Digital Health – Hype or Reality?

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com

About Galen Growth: 1 page

Digital Health in Biopharma Research: 9 pages, 9 charts, 1 table

Key Information

Full access

Need full access to this research?

Contact Galen Growth to discuss full report access, advisory support, and HealthTech Alpha intelligence for your team. We will help you identify the right level of research access for your organization.

Full report access and downloadable research
HealthTech Alpha digital health intelligence
Advisory support for market, funding, and ecosystem analysis

Research context